Raising Capital

Raising capital is one of the most difficult challenges facing any venture. Matthew Kane, MBA'06 will share his personal experiences leading Precision BioSciences through its capital raising process. Regardless of the stage of your venture, learning from someone who has traveled through this long hard journey can be essential to your future success.

About Precision BioSciences
Precision BioSciences' mission is to translate the world's most powerful genome editing technology into greatly needed products throughout the life sciences. Precision's proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Precision BioSciences' vision is to be the conduit through which the greatest genome engineering challenges are solved. Precision is developing genome editing-based products to address critical needs in human health, agriculture, and beyond. For additional information, please visit www.precisionbiosciences.com.